SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-016043
Filing Date
2021-11-15
Accepted
2021-11-15 17:24:01
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210930x10q.htm   iXBRL 10-Q 1436193
2 EX-10.1 tmb-20210930xex10d1.htm EX-10.1 29987
3 EX-10.2 tmb-20210930xex10d2.htm EX-10.2 34777
4 EX-31.1 tmb-20210930xex31d1.htm EX-31.1 10626
5 EX-31.2 tmb-20210930xex31d2.htm EX-31.2 10420
6 EX-32.1 tmb-20210930xex32d1.htm EX-32.1 6708
7 EX-32.2 tmb-20210930xex32d2.htm EX-32.2 6331
  Complete submission text file 0001558370-21-016043.txt   6194436

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20210930.xsd EX-101.SCH 47365
9 EX-101.CAL tmb-20210930_cal.xml EX-101.CAL 36704
10 EX-101.DEF tmb-20210930_def.xml EX-101.DEF 173154
11 EX-101.LAB tmb-20210930_lab.xml EX-101.LAB 414995
12 EX-101.PRE tmb-20210930_pre.xml EX-101.PRE 318512
13 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210930x10q_htm.xml XML 1071798
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 211412592
SIC: 2834 Pharmaceutical Preparations